Wnt signaling inhibitor APL-5125
Term · Oncology and biomedicine · MLC-T-ONC-017565
An orally bioavailable small molecule kinase inhibitor of the Wnt signaling pathway, with potential antineoplastic activity. Upon oral administration, Wnt signaling inhibitor APL-5125 targets and binds to an as of yet undisclosed kinase in the Wnt signaling pathway, thereby preventing Wnt-mediated signaling. This may inhibit growth of tumor cells in which the Wnt signaling pathway is overactivated. The Wnt signaling pathway is upregulated in many cancers and plays a key role in tumor cell proliferation.
| Identifier | MLC-T-ONC-017565 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | kinase inhibitor APL-5125 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017565",
"term": "Wnt signaling inhibitor APL-5125",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable small molecule kinase inhibitor of the Wnt signaling pathway, with potential antineoplastic activity. Upon oral administration, Wnt signaling inhibitor APL-5125 targets and binds to an as of yet undisclosed kinase in the Wnt signaling pathway, thereby preventing Wnt-mediated signaling. This may inhibit growth of tumor cells in which the Wnt signaling pathway is overactivated. The Wnt signaling pathway is upregulated in many cancers and plays a key role in tumor cell proliferation.",
"synonyms": [
"kinase inhibitor APL-5125"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/wnt-signaling-inhibitor-apl-5125/"
}
Record 17,440 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.